VEEV offers cloud computing products and services for life sciences work. Its products have specific functionality and regulatory compliance by design. VEEV allows its pharmaceutical and other clients to benefit from modern IT solutions while also adhering to industry standards and requirements. The company’s ongoing AI integration with larger clients is proving successful, and plans remain to migrate AI to all clients in the future.

As for earnings, VEEV’s first-quarter 2026 report showed nearly $759 million in quarterly revenue, which beat guidance, and an operating margin of 46%. Net income was $228.2 million versus $161.7 million one year ago, an increase of 41% on a year-over-year basis. Also, the company’s fully diluted net income per share was $1.37, compared to $0.98 a year prior.

It’s no wonder VEEV shares are up 35% this year – and they could rise more. MoneyFlows data shows how Big Money investors are once again betting heavily on the forward picture of the stock.

Institutional volumes reveal plenty. In the last year, VEEV has enjoyed strong investor demand, which we believe to be institutional support.

Each green bar signals unusually large volumes in VEEV shares. They reflect our proprietary inflow signal, pushing the stock higher:

Plenty of health care names are under accumulation right now. But there’s a powerful fundamental story happening with Veeva.

Institutional support and a healthy fundamental backdrop make this company worth investigating. As you can see, VEEV has had strong sales and earnings growth:

• 3-year sales growth rate (+14.1%)

• 3-year EPS growth rate (+17.2%)

Source: FactSet

Also, EPS is estimated to ramp higher this year by +8.8%.

Now it makes sense why the stock has been generating Big Money interest. VEEV has a track record of strong financial performance.

Marrying great fundamentals with our proprietary software has found some big winning stocks over the long term.

Veeva has been a top-rated stock at MoneyFlows. That means the stock has unusual buy pressure and growing fundamentals. We have a ranking process that showcases stocks like this on a weekly basis.

It’s made the rare Outlier 20 report multiple times in the last year. The blue bars below show when VEEV was a top pick…sending shares upwards:

Tracking unusual volumes reveals the power of money flows.

This is a trait that most outlier stocks exhibit…the best of the best. Big Money demand drives stocks upward.

The VEEV action isn’t new at all. Big Money buying in the shares is signaling to take notice. Given the historical gains in share price and strong fundamentals, this stock could be worth a spot in a diversified portfolio.